1. Home
  2. SPRO vs BTCM Comparison

SPRO vs BTCM Comparison

Compare SPRO & BTCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPRO
  • BTCM
  • Stock Information
  • Founded
  • SPRO 2013
  • BTCM 2001
  • Country
  • SPRO United States
  • BTCM United States
  • Employees
  • SPRO N/A
  • BTCM N/A
  • Industry
  • SPRO Biotechnology: Pharmaceutical Preparations
  • BTCM EDP Services
  • Sector
  • SPRO Health Care
  • BTCM Technology
  • Exchange
  • SPRO Nasdaq
  • BTCM Nasdaq
  • Market Cap
  • SPRO 33.0M
  • BTCM 30.3M
  • IPO Year
  • SPRO 2017
  • BTCM 2013
  • Fundamental
  • Price
  • SPRO $3.02
  • BTCM $1.94
  • Analyst Decision
  • SPRO Buy
  • BTCM Hold
  • Analyst Count
  • SPRO 4
  • BTCM 1
  • Target Price
  • SPRO $5.00
  • BTCM N/A
  • AVG Volume (30 Days)
  • SPRO 12.5M
  • BTCM 57.7K
  • Earning Date
  • SPRO 08-04-2025
  • BTCM 07-21-2025
  • Dividend Yield
  • SPRO N/A
  • BTCM N/A
  • EPS Growth
  • SPRO N/A
  • BTCM N/A
  • EPS
  • SPRO N/A
  • BTCM 0.62
  • Revenue
  • SPRO $44,584,000.00
  • BTCM $32,921,999.00
  • Revenue This Year
  • SPRO N/A
  • BTCM $14.32
  • Revenue Next Year
  • SPRO N/A
  • BTCM N/A
  • P/E Ratio
  • SPRO N/A
  • BTCM $2.58
  • Revenue Growth
  • SPRO N/A
  • BTCM N/A
  • 52 Week Low
  • SPRO $0.51
  • BTCM $1.22
  • 52 Week High
  • SPRO $3.06
  • BTCM $4.27
  • Technical
  • Relative Strength Index (RSI)
  • SPRO 79.94
  • BTCM 47.51
  • Support Level
  • SPRO $2.81
  • BTCM $1.88
  • Resistance Level
  • SPRO $3.06
  • BTCM $2.28
  • Average True Range (ATR)
  • SPRO 0.24
  • BTCM 0.18
  • MACD
  • SPRO -0.00
  • BTCM -0.02
  • Stochastic Oscillator
  • SPRO 93.75
  • BTCM 25.26

About SPRO Spero Therapeutics Inc.

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. Besides, it is also focused on SPR206, a next-generation polymyxin investigational product candidate being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.

About BTCM BIT Mining Limited ADS

BIT Mining Ltd is a cryptocurrency mining company, with a long-term plan to encompass the whole cryptocurrency value chain. Its business covers cryptocurrency mining, mining pool, data center operation and mining machine manufacturing. The company has a significant and growing deployed Bitcoin mining machine capacity, owns three hydroelectric cryptocurrency mines with combined power capacity of 435MW and the entire mining pool business operated under BTC.com, including the domain name and wallet. It has also entered into a definitive agreement to acquire a 7 nanometer cryptocurrency mining machine manufacturer "Bee Computing", completing its vertical integration, making self-sufficient while also strengthening competitive position.

Share on Social Networks: